Acthar Gel for dry eye and autoimmune disease
Part of Eyes & vision, Immune system & allergy clinical trials.
This trial tests a new injectable medicine, Acthar Gel, for moderate to severe dry eye and eye pain linked to autoimmune disease. It aims to see if the drug can relieve these symptoms safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have had dry eye for at least 6 months.
- You have an autoimmune disease (like Sjögren's, lupus, or rheumatoid arthritis).
- You have corneal nerve damage causing eye pain, confirmed by a special microscope.
- A numbing eye drop relieves your eye pain for at least 15 minutes.
- You have not used the study drug (Acthar Gel) before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether eye drops made from your own blood serum (with a natural lubricant) can relieve moderate-to-severe dry eye better than a standard salt solution. If you have dry eye from certain immune conditions or nerve damage, this may help find a more effective treatment.
This trial tests a new eye drop (acoltre mon) to see if it helps people who have both dry eyes and nerve-related eye pain. The drops may increase tear production and reduce burning or light sensitivity.
This trial tests whether low-level light therapy can improve dry eye disease by measuring changes in tear proteins. It may help people with chronic dry eye who are interested in a non-drug treatment.
This study tests an experimental eye drop for people with dry eye disease. It aims to see if the drops can reduce symptoms and signs of dry eye.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This trial tests a new eye gel that contains cyclosporine (a medicine that lowers inflammation) to see if it helps with dry eye symptoms. If you have long-lasting dry eye, this study might offer a new treatment option.
Hear when a new Autoimmune Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.